Is pseudoexfoliation glaucoma a neurodegenerative disorder?
Biswajit Padhy1, Debasmita Pankaj Alone
1School of Biological Sciences, National Institute of Science Education and Research (NISER) Bhubaneswar, Khurda 752 050, India.
Journal of Biosciences
|November 17, 2021
Summary
Pseudoexfoliation (PEX) is an age-related disorder affecting the eye. New research suggests PEX, including pseudoexfoliation glaucoma (PEXG), is a neurodegenerative disease sharing traits with conditions like Alzheimer's.
Area of Science:
- Ophthalmology
- Neuroscience
- Genetics
Background:
- Pseudoexfoliation (PEX) is a systemic, age-related disorder impacting ocular tissues.
- Pseudoexfoliation syndrome (PEXS) involves fibrillar aggregate deposition, leading to pseudoexfoliation glaucoma (PEXG), a common secondary glaucoma.
- Recent research indicates PEX may be a neurodegenerative disorder.
Purpose of the Study:
- To review and compare the pathological mechanisms of PEXG with neurodegenerative diseases.
- To categorize PEXG as a progressive neurodegenerative disorder based on shared features.
Main Methods:
- Literature review comparing PEXG pathology with neurodegenerative disorders.
- Analysis of epidemiological studies linking PEX with other neurodegenerative conditions.
- Examination of shared genetic risk factors and protein aggregation patterns.
Main Results:
- PEX shares common features with neurodegenerative diseases, including Alzheimer's and age-related macular degeneration.
- Shared characteristics include genetic risk factors, abnormal protein aggregation, and neuronal degeneration.
- PEXG exhibits progressive neuronal degeneration similar to other neurodegenerative conditions.
Conclusions:
- Pseudoexfoliation glaucoma (PEXG) can be categorized as a progressive neurodegenerative disorder.
- Understanding PEXG as a neurodegenerative condition may offer new therapeutic avenues.
- Further research into shared pathways could illuminate PEX pathogenesis and treatment.
Related Concept Videos
Glaucoma: Overview
961
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
961
Photoreceptors and Visual Pathways
6.8K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
6.8K
Open Angle Glaucoma: Treatment
748
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
748
Angle Closure Glaucoma: Treatment
886
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
886
Parkinson's Disease: Overview
824
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
824
Neural Regulation
40.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.5K


